Patents
Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
06/2005
06/28/2005CA2259977C Taxane derivatives and drugs containing the same
06/28/2005CA2154071C Process for preparation of taxane derivatives and .beta.-lactam intermediates therefor
06/22/2005EP1263749B1 Taxane anticancer agents
06/22/2005CN1629150A Paclitaxol predrug of biodegradable polymer and its synthesis method
06/22/2005CN1628506A Method for producing paclitaxel using isolated plant tissue
06/15/2005EP1539690A2 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
06/14/2005US6906101 Taxane derivatives and processes for the preparation thereof
06/14/2005US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent
06/09/2005US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage
06/08/2005EP1537094A2 Methods and compositions for converting taxane amides to paclitaxel or other taxanes
06/08/2005EP1537093A2 Taxane derivatives functionalized at the 14- position and a process for the preparation thereof
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1623989A Process for extracting taxad alcohol
06/08/2005CN1205197C Method and apparatus fr preparing taxol using supercritical fluid from source materials
06/08/2005CN1205196C Process for selective derivatization of taxanes
06/08/2005CN1205184C Beta-lactan
06/08/2005CN1204886C Condensation derivatives of thiocolchicine and baccatin and its composition
06/01/2005EP1534674A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use
06/01/2005EP1461315A4 Catalytic carbonylation of three and four membered heterocycles
05/2005
05/31/2005CA2158275C Taxanes having an amino substituted side-chain
05/26/2005WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
05/26/2005US20050113585 novel intermediates useful in the synthesis of 14 beta -hydroxy-1,14-carbonate-deacetylbaccatin III derivatives; 7,10-bistrichloroacetyl-10-deacetylbaccatin III; 13-dehydro-14 beta -hydroxy-7-triethylsilylbaccatin III; 13-dehydro-14 beta -hydroxy-7,10-bistrichloroacetyl-baccatin III 1,14-carbonate
05/25/2005CN1203074C Pentacycle taxane compounds
05/24/2005CA2246541C Intermediate for use in docetaxel synthesis and production method therefor
05/19/2005WO2005044811A2 Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin iii
05/19/2005US20050107605 Novel beta-lactams methods for the preparation of taxanes, and sidechain-bearing taxanes
05/18/2005CN1616442A Method for extracting 9-dihydrogen-13-acetyl baccatin III and taxol
05/18/2005CN1616441A Method for extracting 10-deacetyl baccatin III
05/18/2005CN1202116C Avermectin derivatives
05/18/2005CN1202099C Method for extracting and purifying 10-desacetyl bakading III (10-DABIII)
05/12/2005WO2005041881A2 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
05/12/2005US20050101789 Protected baccatin III backbone from 9-dihydro-13-acetylbaccatin III, protected baccatin III from 9-dihydro-13-acetylbaccatin III to form the taxane derivatives, paclitaxel and docetaxel
05/12/2005US20050101752 E.g., 2-[p-(p-[p-(3-ethyl-3-oxetanylmethoxy)benzoyl]phenoxycarbonyl)phenoxy]ethyl acrylate; excellent in reactivity upon fixation of the liquid crystal orientation structure
05/12/2005US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors
05/12/2005CA2544128A1 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
05/11/2005EP1529777A2 Process and oxazolidine intermediate for the synthesis of taxanes
05/11/2005CN1615130A Taxane based compositions and methods of use
05/11/2005CN1613863A Extracting method for taxane compound
05/11/2005CN1200706C Compositions and methods for treating or preventing inflammatory diseases
05/10/2005US6891050 Use of haloalkyl acid chlorides as protecting groups for both 7 and 10 hydroxy, these protecting group undergo hydrolysis faster, and deprotect these group without many side products in presence of acetyl group
05/10/2005US6891013 Exhibit hydrophobic properties, very low surface energies, low glass transition temperatures, low dielectric constants, high abrasion resistance and tear strength, low coefficient of friction, high adhesion and low refractive indices
05/10/2005US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation
05/06/2005WO2005040357A2 Compounds and methods for fluorescent labeling
05/04/2005CN1611496A Method for preparing high-purity taxol using high-pressure liquid-phase chromatogram
05/04/2005CN1199959C Percyquuinnin, process for its production and its use pharmaceutical
04/2005
04/28/2005US20050090484 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy
04/28/2005US20050089978 Solvent extraction of lipstatin from the fermenation broth uisng multi solvent extraction
04/21/2005US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections
04/19/2005US6881852 Mixing plant extracts with solvents, then filtering solids to remove impuritiesand drying to obtain anticarcinogenic agents; solvent extraction
04/19/2005CA2299967C Taxoid compound and method for producing the same
04/13/2005EP1458702B1 Luminacin analogs and uses thereof
04/13/2005CN1606543A Alpha-cyanoacrylates
04/13/2005CN1196691C Process for converting 9-dihydro-13-acetylbaccatin III into taxoland derivatives thereof
04/12/2005US6878834 Selectively reduced to the corresponding hydroxy group
04/12/2005US6878833 Tetraalkylammonium alkoxides
04/12/2005US6878832 Filtering by liquid column chromatography, enriching by precipitation and crystallization, dissolving in polar organic solvent mixture of alcohol and non-alcohol solvent
04/07/2005WO2005030150A2 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF
04/07/2005WO2005005403A3 Process for preparation of oxetan-2-ones
04/06/2005EP1470116A4 Preparation of orlistat and orlistat crystalline forms
04/05/2005US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
03/2005
03/31/2005WO2005028462A1 Dimethoxy docetaxel acetone solvate et method for the preparation thereof
03/31/2005WO2004083176A3 Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins
03/31/2005CA2539309A1 Dimethoxy docetaxel acetone solvate et method for the preparation thereof
03/30/2005EP1517975A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
03/29/2005US6872842 Butenyl substituted taxanes
03/29/2005US6872837 Taxanes having a c10 Heterosubstituted acetate substituent
03/24/2005WO2005026140A1 Process for the preparation of crystalline forms of orlistat
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005US20050065138 Acetone solvate of dimethoxy docetaxel and its process of preparation
03/23/2005EP1516015A1 Low acidity phosphate esters
03/23/2005CN1193992C Synthesis of 3.6-dialkyl 5.6-dihydro-4-hydroxide-2H-pyran-2-ketone
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/16/2005CN1596250A Paclitaxel solvates
03/16/2005CN1594247A Yew genus plant extract and its extraction method and application
03/10/2005US20050054863 Chemical intermediates for preparing taxane antitumor agents; forming paclitaxel derivatives by silation, esterification, carbonation, catalylic hydrogenation; protecting the 7-hydroxyl paclitaxel precursor using a strong base lithium tert-butoxide
03/09/2005CN1590386A Sidechain-bearing taxanes and method for the preparation thereof
03/03/2005US20050049297 Semi-synthetic process for the preparation of N-debenzoylpaclitaxel
03/02/2005CN1589157A Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin
03/02/2005CN1587262A High voltage discharge reactor and method for directly synthesizing epoxy propane from propene and oxygen
03/02/2005CN1191366C Process for extracting taxol from taxus cuspidata
03/02/2005CN1191263C 3-deoxy-desmycosin derivatives and process for their preparation
03/01/2005US6861537 Tricyclic and tetracyclic taxane intermediates
03/01/2005US6861446 C7 heterosubstituted acetate taxane compositions
02/2005
02/24/2005WO2005016904A1 Process for preparing 4-alkyl-or 4-aryl-oxycarbonyl paclitaxel analogs and novel intermediates
02/24/2005WO2005016340A1 Furanone derivatives
02/24/2005WO2004014960A3 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
02/22/2005US6858749 Process for enantioselectively producing the (R)-delta-lactone
02/22/2005US6858644 Use as anti-tumor agents; examples of solvents are N-methyl-2-pyrrolidone and acetonitrile
02/22/2005CA2310778C Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
02/16/2005EP1506181A1 Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
02/16/2005EP1064285B1 Novel cephalotaxane derivatives and process for their preparation
02/08/2005US6852865 Epoxides, aziridines, thiiranes, oxetanes, lactones, lactams and analogous compounds are reacted with carbon monoxide in the presence of a catalytically effective amount of catalyst complex of transition metal carbonyl and Lewis acid
02/03/2005US20050026997 Baccatin III analog containing a small peptide moiety; can be conjugated to cell binding agents; improved potency
02/03/2005US20050026996 A taxane such as paclitaxel or docetaxel joined by a hydrolyzable bond to one or more oligomers having a polyethylene glycol moiety; amphiphilic drug conjugate with improved water solubility without drastic increase in molecular weight
02/03/2005US20050026995 anticarcinogenic agents comprising a mixture of taxol, solubilizers, stabilizers and anhydrous ethanol, having superior solubility, stability, bioavailability and side effect reduction
02/02/2005EP0935596B1 Method for paclitaxel synthesis
02/02/2005CN1187347C Chromatographic separation method of paclitaxel and cephalomannin
01/2005
01/27/2005WO2005007639A1 Preparation of tetrahydrolipstatin by hydrogenation of lipstatin, solvent extraction and purification
01/27/2005US20050020669 Process for the preparation of the 14beta-hydroxy-baccatin III-1, 14-carbonate
01/27/2005US20050020635 C7 carbamoyloxy substituted taxane compositions
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 55